Topiramate and status epilepticus: Report of three cases

Epilepsy and Behavior

Volumn 4, Issue 6, 2003, Pages 757-760

  Bensalem, Meriem K ^a   Fakhoury, Toufic A ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Generalized; Partial; Status epilepticus; Topiramate

Indexed keywords

ACICLOVIR; DOXYCYCLINE; FOSPHENYTOIN SODIUM; GENTAMICIN; LORAZEPAM; PENTOBARBITAL; PHENYTOIN; PROPOFOL; SULFAMETHOXAZOLE; TOPIRAMATE; TRIMETHOPRIM; VALPROIC ACID;

ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; BLEEDING; BRAIN DISEASE; CARDIOPULMONARY ARREST; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; ENCEPHALITIS; EPILEPTIC DISCHARGE; EPILEPTIC STATE; ESOPHAGUS VARICES; FOLLOW UP; HEALTH CARE FACILITY; HEALTH STATUS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LIVER DISEASE; MALE; MENTAL HEALTH; NEUROLOGIC EXAMINATION; PARIETAL LOBE; RECORDING; RECURRENT DISEASE; SEIZURE; SLOW BRAIN WAVE;

EID: 0346787771     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2003.07.016     Document Type: Article

References (18)

1. Bourgeois B. Pharmacokinetic properties of antiepileptic drugs. Epilepsia 1995;36:S1-7.
2. Bourgeois B. Pharmacokinetic properties of current antiepileptic drugs: what improvements are needed? Neurology 2000;55:S11-7.
3. Johannessen SI. Pharmacokinetics and interaction profile of topiramate: review and comparison with other newer antiepileptic drugs. Epilepsia 1997;38:S18-23.
4. Bourgeois B. Pharmacokinetics and pharmacodynamics of topiramate. J Child Neurol 2000;15:S27-30.
5. Treiman DM, Walton NY, Kendrick C. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49-60.
6. Reuber M, Evans J, Bamford JM. Topiramate in drug-resistant complex partial status epilepticus. Eur J Neurol 2002;9:111-2.
7. Rhoney DH et al. Rapid topiramate dose escalation in critically ill patients (abstract). Epilepsia 2002;43:S241.
8. Towne AR, Garnett LK, Waterhouse EJ, Morton LD. The use of topiramate in refractory status epilepticus. Neurology 2003;60:332-4.
9. Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-4.
10. Jagoda A, Riggio S. Refractory status epilepticus in adults. Ann Emerg Med 1993;22:1337-48.
11. Mayer SA, Claasen J, Lokin J, Mendelson F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors and impact on outcome. Arch Neurol 2002;59:205-10.
12. Bleck TP. Advances in the management of refractory status epilepticus. Crit Care Med 1993;21:955-7.
13. Lowenstein DH, Alldredge BK. Status epilepticus in an urban public hospital in the 1980s. Neurology 1993;43:483-8.
14. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998;339:792-8.
15. Niebauer M, Gruenthal M. Topiramate reduces neuronal injury after experimental status epilepticus. Brain Res 1999;837:263-9.
16. Lee SR, Kim JE. Protective effect of topiramate against hippocampal neuronal damage after global ischemia in the gerbils. Neurosci Lett 2000;281:183-6.
17. Cavazos JE, Kanske J, Perez J, et al. Neuroprotective effects of topiramate in the kainic acid model of status epilepticus. Epilepsia 2002;43(7):S15.
18. DeLorenzo RJ, Morris TA, Blair RE, et al. Topiramate is both neuroprotective and antiepileptogenic in the pilocarpine model of status epilepticus. Epilepsia 2002;43(7):S15.